🏅 FDA Orphan Designation
DORC ILM-Blue
Brilliant Blue G Ophthalmic Solution 0.025%
Manufacturer: Dutch Ophthalmic Research Center International BV
Indicated for:
FDA-Approved Indications (1)
Rare genetic ophthalmic disorder with cortical involvementOrphan Designation
TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025% is indicated to selectively stain the internal limiting membrane (ILM).
Indications & Usage
TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025% is indicated to selectively stain the internal limiting membrane (ILM).
💙 Support Programs
View all →DORC ILM-Blue
Dutch Ophthalmic Research Center International BV
DORC ILM-Blue
Dutch Ophthalmic Research Center International BV
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.